{"url":"https://lda.senate.gov/api/v1/filings/60e2ec6d-9c05-4ca7-ba85-e746ffc8791a/","filing_uuid":"60e2ec6d-9c05-4ca7-ba85-e746ffc8791a","filing_type":"RR","filing_type_display":"Registration","filing_year":2013,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/60e2ec6d-9c05-4ca7-ba85-e746ffc8791a/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Danielle Organ Peters","dt_posted":"2014-01-31T16:00:10.340000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2200 Pennsylvania Ave, NW","registrant_address_2":"Suite 200E","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":400427062,"url":"https://lda.senate.gov/api/v1/registrants/400427062/","house_registrant_id":null,"name":"DANIELLE ORGAN PETERS","description":"Government and Public Affairs","address_1":"2200 Pennsylvania Ave, NW","address_2":"Suite 200E","address_3":"Toronto","address_4":"ON M4V1V8","city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"CA","ppb_country_display":"Canada","contact_name":"DANIELLE ORGAN PETERS","contact_telephone":"+1 202-803-4208","dt_updated":"2022-04-06T16:07:55.231437-04:00"},"client":{"id":190708,"url":"https://lda.senate.gov/api/v1/clients/190708/","client_id":214,"name":"NANOTHERAPEUTICS INC","general_description":"Biopharmaceutical R&D and manufacturing","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-10-01"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Raise awareness about company's Accelerated Development and Manufacturing (ADM) Center and network","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":47630,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"ORGAN PETERS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Raise awareness about company's Accelerated Development and Manufacturing (ADM) Center and network","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":47630,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"ORGAN PETERS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}